Paper · 42978490
The Potential Role of Gut Microbiome Dysbiosis and Functional Reprogramming in Colorectal Liver Metastasis via the Gut-Liver Axis.
Sheng Y and 4 others. Cancer Rep (Hoboken), 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Potential Role of Gut Microbiome Dysbiosis and Functional Reprogramming in Colorectal Liver Metastasis via the Gut-Liver Axis. Papers, record 42978490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42978490
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Potential Role of Gut Microbiome Dysbiosis and Functional Reprogramming in Colorectal Liver Metastasis via the Gut-Liver Axis.
- Journal
- Cancer Rep (Hoboken)
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-11-06
Source PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Neoplasms | Major topic |
| Colorectal Neoplasms | Major topic |
| Dysbiosis | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Humans | |
| Male | |
| Female | |
| Feces | |
| Middle Aged | |
| Aged | |
| Liver | |
| Case-Control Studies | |
| Metagenomics | |
| Biomarkers, Tumor |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2024KY1551 | Medical Scientific Research Foundation of Zhejiang Province, China | PubMed | ||
| 2025KY1386 | Medical Scientific Research Foundation of Zhejiang Province, China | PubMed | ||
| 2025KY1503 | Medical Scientific Research Foundation of Zhejiang Province, China | PubMed | ||
| 2024Z229 | Science and Technology Innovation Yongjiang 2035 Key Research and Development Project of Ningbo | PubMed | ||
| 2022E50008 | Zhejiang Provincial Clinical Research Center for CANCER | PubMed | ||
| 2024ZY01056 | Zhejiang Provincial Clinical Research Center for CANCER | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21,111,231 | Pathogen-mediated posttranslational modifications: A re-emerging field. | Cell | 2010 | https://conductscience.org/library/papers/21111231 | PubMed |
| 2 | 15,729,348 | Functional cartography of complex metabolic networks. | Nature | 2005 | https://conductscience.org/library/papers/15729348 | PubMed |
| 3 | 24,695,404 | Trimmomatic: a flexible trimmer for Illumina sequence data. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24695404 | PubMed |
| 4 | 29,170,280 | Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. | Science | 2017 | https://conductscience.org/library/papers/29170280 | PubMed |
| 5 | 26,684,538 | Bacterial ferrous iron transport: the Feo system. | FEMS Microbiol Rev | 2016 | https://conductscience.org/library/papers/26684538 | PubMed |
| 6 | 31,455,888 | Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. | Nat Rev Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/31455888 | PubMed |
| 7 | 33,277,504 | Deciphering functional redundancy in the human microbiome. | Nat Commun | 2020 | https://conductscience.org/library/papers/33277504 | PubMed |
| 8 | 36,992,683 | Tumor bacterial markers diagnose the initiation and four stages of colorectal cancer. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/36992683 | PubMed |
| 9 | 25,758,642 | Gut microbiome development along the colorectal adenoma-carcinoma sequence. | Nat Commun | 2015 | https://conductscience.org/library/papers/25758642 | PubMed |
| 10 | 16,731,699 | Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. | Bioinformatics | 2006 | https://conductscience.org/library/papers/16731699 | PubMed |
1 to 10 of 74
See all 74 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42978490
GET https://conductscience.org/api/papers/v1/42978490/references?page=2